Your browser doesn't support javascript.
loading
Efectos adversos de finasteride: mitos y realidades. una revisión actualizada / Finasteride adverse effects: an update
Carreño-Orellana, Néstor; Moll-Manzur, Catherina; Carrasco-Zuber, Juan Eduardo; Álvarez-Véliz, Sergio; Berroeta-Mauriziano, Daniela; Porras-Kusmanic, Ninoska.
Affiliation
  • Carreño-Orellana, Néstor; Pontificia Universidad Católica de Chile. Facultad de Medicina. Departamento de Dermatología. Santiago. CL
  • Moll-Manzur, Catherina; Pontificia Universidad Católica de Chile. Facultad de Medicina. Departamento de Dermatología. Santiago. CL
  • Carrasco-Zuber, Juan Eduardo; Pontificia Universidad Católica de Chile. Facultad de Medicina. Departamento de Dermatología. Santiago. CL
  • Álvarez-Véliz, Sergio; Pontificia Universidad Católica de Chile. Facultad de Medicina. Departamento de Dermatología. Santiago. CL
  • Berroeta-Mauriziano, Daniela; Pontificia Universidad Católica de Chile. Facultad de Medicina. Departamento de Dermatología. Santiago. CL
  • Porras-Kusmanic, Ninoska; Pontificia Universidad Católica de Chile. Facultad de Medicina. Departamento de Dermatología. Santiago. CL
Rev. méd. Chile ; 144(12): 1584-1590, dic. 2016.
Article in Spanish | LILACS | ID: biblio-845489
Responsible library: CL1.1
ABSTRACT
Finasteride is a 5-α reductase inhibitor that is widely used in the management of benign prostate hyperplasia and male pattern hair loss. It is well known that these agents improve the quality of life in men suffering from these conditions. However, they are associated with some transient and even permanent adverse effects. The aim of this article is to clarify the controversies about the safety of finasteride by analyzing the evidence available in the literature.
Subject(s)

Fulltext
Add to My VHL
Print
XML
Search on Google

Full text: Available Collection: International databases Health context: Sustainable Health Agenda for the Americas / SDG3 - Health and Well-Being Health problem: Goal 9: Noncommunicable diseases and mental health / Target 3.4: Reduce premature mortality due to noncommunicable diseases Database: LILACS Main subject: Finasteride / 5-alpha Reductase Inhibitors Aspects: Patient-preference Limits: Humans / Male Language: Spanish Journal: Rev. méd. Chile Journal subject: Medicine Year: 2016 Document type: Article Affiliation country: Chile Institution/Affiliation country: Pontificia Universidad Católica de Chile/CL
Fulltext
Add to My VHL
Print
XML
Search on Google

Full text: Available Collection: International databases Health context: Sustainable Health Agenda for the Americas / SDG3 - Health and Well-Being Health problem: Goal 9: Noncommunicable diseases and mental health / Target 3.4: Reduce premature mortality due to noncommunicable diseases Database: LILACS Main subject: Finasteride / 5-alpha Reductase Inhibitors Aspects: Patient-preference Limits: Humans / Male Language: Spanish Journal: Rev. méd. Chile Journal subject: Medicine Year: 2016 Document type: Article Affiliation country: Chile Institution/Affiliation country: Pontificia Universidad Católica de Chile/CL